Targeting the hypoxia pathway to treat pancreatic cancer

Drug Des Devel Ther. 2015 Apr 8:9:2029-31. doi: 10.2147/DDDT.S80888. eCollection 2015.

Abstract

The correlation between hypoxia and pancreatic cancer has long been discussed. Hao's research team made many efforts on revealing the oncogenic function of hypoxic inducible factor-1 (HIF-1) in pancreatic cancer progression and development in recent years. Based on their research, they linked micro-environmental regulation of pancreatic cancer and its clinical significance. Hao's research team suggests it is a promising approach to target HIF-1 for the management of pancreatic cancer progression and invasion.

Keywords: HIF-1; hypoxia; pancreatic cancer.

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Hypoxia / drug therapy*
  • Hypoxia / metabolism*
  • Hypoxia-Inducible Factor 1 / antagonists & inhibitors*
  • Hypoxia-Inducible Factor 1 / metabolism
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / metabolism*

Substances

  • Antineoplastic Agents
  • Hypoxia-Inducible Factor 1